Viemed Healthcare, Inc. (NASDAQ:VMD) Director Buys $19,965.60 in Stock

Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sabrina Heltz bought 2,820 shares of the business’s stock in a transaction that occurred on Tuesday, May 14th. The shares were acquired at an average price of $7.08 per share, for a total transaction of $19,965.60. Following the completion of the transaction, the director now owns 41,040 shares in the company, valued at $290,563.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Viemed Healthcare Stock Up 0.7 %

Shares of NASDAQ VMD opened at $6.97 on Thursday. The company has a market capitalization of $270.58 million, a P/E ratio of 26.62 and a beta of 1.53. Viemed Healthcare, Inc. has a 52-week low of $5.90 and a 52-week high of $10.79. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.14 and a current ratio of 1.28. The company’s 50 day moving average price is $8.52 and its 200-day moving average price is $8.14.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Wednesday, March 6th. The company reported $0.09 earnings per share (EPS) for the quarter. The firm had revenue of $50.74 million for the quarter. Viemed Healthcare had a net margin of 5.32% and a return on equity of 9.32%.

Analyst Ratings Changes

Separately, Lake Street Capital upgraded shares of Viemed Healthcare to a “strong-buy” rating in a research report on Tuesday, May 7th.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of Viemed Healthcare by 53.0% in the 1st quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after acquiring an additional 617,009 shares in the last quarter. Bard Associates Inc. increased its stake in shares of Viemed Healthcare by 882.0% in the 4th quarter. Bard Associates Inc. now owns 338,335 shares of the company’s stock valued at $2,656,000 after acquiring an additional 303,880 shares in the last quarter. Cove Street Capital LLC increased its stake in shares of Viemed Healthcare by 27.0% in the 3rd quarter. Cove Street Capital LLC now owns 944,197 shares of the company’s stock valued at $6,590,000 after acquiring an additional 200,466 shares in the last quarter. Millrace Asset Group Inc. bought a new stake in shares of Viemed Healthcare in the 4th quarter valued at $1,458,000. Finally, Spartan Fund Management Inc. bought a new stake in shares of Viemed Healthcare in the 4th quarter valued at $983,000. Institutional investors and hedge funds own 74.24% of the company’s stock.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.